John McAdory
Fortune : - $ au 31/07/2026
Fortune : - $ au 31/07/2026
John McAdory is Chief Operating Officer at Oncolytics Biotech, Inc. since 2026.
Formerly, Mr. McAdory was Vice President-Clinical Operations at CG Oncology, Inc. from 2020 to 2026.
Education includes undergraduate studies at Hampton University and graduate studies at The University of North Carolina at Chapel Hill.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Directeur des opérations | 14/01/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| CG ONCOLOGY, INC. | Directeur Technique/Scientifique/R&D | 01/01/2026 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Oncolytics Biotech, Inc.
Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Hampton University
Hampton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CG Oncology, Inc.
CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national